Meloxicam

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

60 Suppliers, 23 USDMF, 14 CEP/COS, 7 JDMF, 15 EU WC, 25 KDMF, 21 NDC API, 36 Listed Suppliers

DEVELOPMENTS

43 Drug(s) in Development

43 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

13 Suppliers

13 Suppliers

DOSSIERs // Finished Dosage Forms

314 Dossiers, 62 FDA Orange Book, 63 Europe, 34 Canada, 36 Australia, 44 South Africa, 75 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 15MG, TABLET;ORAL - 7.5MG, SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 7.5MG/5ML

RELATED EXCIPIENT COMPANIES

Suppliers, 27 Roquette, 26 Kerry, 20 BASF, 12 Microlex e.U, 11 Sigachi Industries, 11 Gangwal Healthcare, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 SPI Pharma, 7 Boai NKY Pharmaceuticals Ltd, 7 DFE Pharma, 7 Gangwal Chemicals, 7 Actylis, 5 Prachin Chemical, 5 Pharmatrans-Sanaq, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Vasa Pharmachem, 4 ACG Worldwide, 4 Ingredion Pharma Solutions, 3 Nanjing Well Pharmaceutical, 3 Ulanqab Kema New Material, 3 Lonza Capsugel, 3 Rochem International Inc, 2 DKSH, 2 Ideal Cures Pvt Ltd, 2 Alcedo Pharmachem, 2 Jai Radhe Sales, 2 Zhejiang Huakang Pharmaceutical, 1 NEWEDGE Overseas, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Chynops Pharma, 1 Minakem, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Qualicaps, 1 Nanjing Bold Chemical, 1 Seppic

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 42 Disintegrants & Superdisintegrants, 36 Direct Compression, 25 Granulation, 20 Lubricants & Glidants, 17 Thickeners and Stabilizers, 16 Taste Masking, 15 Coating Systems & Additives, 14 Chewable & Orodispersible Aids, 14 Co-Processed Excipients, 13 Controlled & Modified Release, 11 Solubilizers, 11 Film Formers & Plasticizers, 9 Parenteral, 8 Empty Capsules, 4 Topical, 3 API Stability Enhancers, 2 Rheology Modifiers, 2 Emulsifying Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

25 US Medicaid Prescriptions, 51 Finished Drug Prices

MARKET PLACE

31 APIs, 2 DOSSIERS // FDF, 1 Intermediates

PATENTS

81 US Patents, 4 US Exclusivities, 2 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 5 EDQM Standards, 6 USP Standards, 6 Other Ref. Standards

DIGITAL CONTENT

3 Data Compilation & Company Tracker #PharmaFlow, 42 News

Information, Expiry, & Status of FDA Orange Book Exclusivities covering Meloxicam

Meloxicam

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

60 Suppliers

23 USDMF

14 CEP/COS

7 JDMF

15 EU WC

25 KDMF

21 NDC API

36 Listed Suppliers

DEVELOPMENTS

43 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

13 Suppliers

DOSSIERs // Finished Dosage Forms

314 Dossiers

62 FDA Orange Book

63 Europe

34 Canada

36 Australia

44 South Africa

75 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 15MG

TABLET;ORAL - 7.5MG

SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUSPENSION;ORAL - 7.5MG/5ML

RELATED EXCIPIENT COMPANIES

Suppliers

27 Roquette

26 Kerry

20 BASF

12 Microlex e.U

11 Sigachi Industries

11 Gangwal Healthcare

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 SPI Pharma

7 Boai NKY Pharmaceuticals Ltd

7 DFE Pharma

7 Gangwal Chemicals

7 Actylis

5 Prachin Chemical

5 Pharmatrans-Sanaq

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Vasa Pharmachem

4 ACG Worldwide

4 Ingredion Pharma Solutions

3 Nanjing Well Pharmaceutical

3 Ulanqab Kema New Material

3 Lonza Capsugel

3 Rochem International Inc

2 DKSH

2 Ideal Cures Pvt Ltd

2 Alcedo Pharmachem

2 Jai Radhe Sales

2 Zhejiang Huakang Pharmaceutical

1 NEWEDGE Overseas

1 Shijiazhuang Huaxu Pharmaceutical

1 Chynops Pharma

1 Minakem

1 Shanghai Welltone Material Technology Co., Ltd

1 Qualicaps

1 Nanjing Bold Chemical

1 Seppic

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders

42 Disintegrants & Superdisintegrants

36 Direct Compression

25 Granulation

SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - 15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons